Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
University of Arizona
mi
from
Tucson, AZ
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
University of Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
UCSD Medical Center
mi
from
La Jolla, CA
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
UCSD Medical Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
National Jewish Health
mi
from
Denver, CO
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
National Jewish Health
mi
from
Denver, CO
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Rocky Mountain Center for Clinical Research
mi
from
Wheat Ridge, CO
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Rocky Mountain Center for Clinical Research
mi
from
Wheat Ridge, CO
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Yale-New Haven Hospital
mi
from
New Haven, CT
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Yale-New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Research Alliance, Inc.
mi
from
Clearwater, FL
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Research Alliance, Inc.
mi
from
Clearwater, FL
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
University of Miami
mi
from
Miami, FL
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Central Florida Pulmonary Group, PA
mi
from
Orlando, FL
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Central Florida Pulmonary Group, PA
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
USF Tampa General Hospital
mi
from
Tampa, FL
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
USF Tampa General Hospital
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Florida
mi
from
Weston, FL
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Florida
mi
from
Weston, FL
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Piedmont Healthcare Pulmonary and Critical Care Research
mi
from
Austell, GA
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Piedmont Healthcare Pulmonary and Critical Care Research
mi
from
Austell, GA
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Southeastern Lung Care PC
mi
from
Decatur, GA
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Southeastern Lung Care PC
mi
from
Decatur, GA
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
University of Chicago; Pulmonary and Critical Care
mi
from
Chicago, IL
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
University of Chicago; Pulmonary and Critical Care
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Loyola University Medical Center
mi
from
Maywood, IL
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Loyola University Medical Center
mi
from
Maywood, IL
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Univ of Iowa Hosp & Clinics; Pulmonary
mi
from
Iowa City, IA
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Univ of Iowa Hosp & Clinics; Pulmonary
mi
from
Iowa City, IA
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Uni of Kansas Medical Center
mi
from
Kansas, KA
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Uni of Kansas Medical Center
mi
from
Kansas, KA
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Via Christi Hospital Inc. DBA Via Christi Research; Research Dept.
mi
from
Wichita, KA
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Via Christi Hospital Inc. DBA Via Christi Research; Research Dept.
mi
from
Wichita, KA
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Maine Medical Center -Division of Pulmomary and Critical Care Medicine
mi
from
Portland, ME
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Maine Medical Center -Division of Pulmomary and Critical Care Medicine
mi
from
Portland, ME
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
University of Maryland Medical Center
mi
from
Baltimore, MD
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
University of Maryland Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Bayview Medical Center - Johns Hopkins Asthma & Allergy Center
mi
from
Baltimore, MD
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Bayview Medical Center - Johns Hopkins Asthma & Allergy Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Tufts Medical Center
mi
from
Boston, MA
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
University of Minnesota Hospital & Clinic
mi
from
Minneapolis, MN
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
University of Minnesota Hospital & Clinic
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
University of Nebraska
mi
from
Omaha, NE
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
University of Nebraska
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Lovelace Scientific Resources, Inc.
mi
from
Albuquerque, NM
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Lovelace Scientific Resources, Inc.
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Weill Medical College of Cornell University
mi
from
New York, NY
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Weill Medical College of Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Mt Sinai School Medical Pulmo And Critical Care Med
mi
from
New York, NY
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Mt Sinai School Medical Pulmo And Critical Care Med
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Highland Hospital - University of Rochester Medical Center
mi
from
Rochester, NY
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Highland Hospital - University of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
University of Cincinnati
mi
from
Cincinnati, OH
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Case Western Research University; University Hospitals Case Medical Center
mi
from
Cleveland, OH
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Case Western Research University; University Hospitals Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Ohio State University
mi
from
Columbus, OH
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Oklahoma University Health Sciences Center
mi
from
Oklahoma City, OK
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Oklahoma University Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Oregon Clinic
mi
from
Portland, OR
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Oregon Clinic
mi
from
Portland, OR
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Penn State University College Medical Allergy And Care Med
mi
from
Hershey, PA
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Penn State University College Medical Allergy And Care Med
mi
from
Hershey, PA
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Temple Lung Center, Temple Universtiy-Of the Commomwealth System of Higher Education
mi
from
Philadelphia, PA
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Temple Lung Center, Temple Universtiy-Of the Commomwealth System of Higher Education
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh Med Cen; Dorothy P And Richard P Simmons Cen For Interstitial Lung Disease
mi
from
Pittsburgh, PA
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh Med Cen; Dorothy P And Richard P Simmons Cen For Interstitial Lung Disease
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Baylor College Med
mi
from
Houston, TX
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Baylor College Med
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Houston Methodist Hospital
mi
from
Houston, TX
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Audie Murphy Va Hospital
mi
from
San Antonio, TX
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Audie Murphy Va Hospital
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
University of Utah Health Sciences Center, Lung Health Research Center
mi
from
Salt Lake City, UT
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
University of Utah Health Sciences Center, Lung Health Research Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
University Vermont College Medicine Fletcher Allen Health Care
mi
from
Colchester, VT
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
University Vermont College Medicine Fletcher Allen Health Care
mi
from
Colchester, VT
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Inova Transplant Center Fairfax Hospital
mi
from
Falls Church, VA
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Inova Transplant Center Fairfax Hospital
mi
from
Falls Church, VA
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Pulmonary Consultants, Pllc
mi
from
Tacoma, WA
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Pulmonary Consultants, Pllc
mi
from
Tacoma, WA
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin Hospitals and Clinics
mi
from
Madison, WI
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin Hospitals and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  12/31/1969
Medical College of Wisconsin
mi
from
Milwaukee, WI
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials